vs
Acadia Healthcare Company, Inc.（ACHC）与美森（MATX）财务数据对比。点击上方公司名可切换其他公司
美森的季度营收约是Acadia Healthcare Company, Inc.的1.0倍（$851.9M vs $821.5M），美森净利率更高（16.8% vs -143.3%，领先160.1%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs -4.3%），美森自由现金流更多（$42.2M vs $-179.5M），过去两年美森的营收复合增速更高（8.6% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
美森公司（Matson, Inc.）是美国知名航运服务企业，总部位于夏威夷州火奴鲁鲁，成立于1882年。旗下子公司美森航运主营跨太平洋海运业务，服务覆盖夏威夷、阿拉斯加、关岛、密克罗尼西亚、太平洋诸岛、中国及日本等地区。
ACHC vs MATX — 直观对比
营收规模更大
MATX
是对方的1.0倍
$821.5M
营收增速更快
ACHC
高出10.4%
-4.3%
净利率更高
MATX
高出160.1%
-143.3%
自由现金流更多
MATX
多$221.7M
$-179.5M
两年增速更快
MATX
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $851.9M |
| 净利润 | $-1.2B | $143.1M |
| 毛利率 | — | — |
| 营业利润率 | -142.4% | 16.9% |
| 净利率 | -143.3% | 16.8% |
| 营收同比 | 6.1% | -4.3% |
| 净利润同比 | -3710.4% | 11.8% |
| 每股收益（稀释后） | $-12.98 | $4.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMATX
| Q4 25 | $821.5M | $851.9M | ||
| Q3 25 | $851.6M | $880.1M | ||
| Q2 25 | $869.2M | $830.5M | ||
| Q1 25 | $770.5M | $782.0M | ||
| Q4 24 | $774.2M | $890.3M | ||
| Q3 24 | $815.6M | $962.0M | ||
| Q2 24 | $796.0M | $847.4M | ||
| Q1 24 | $768.1M | $722.1M |
净利润ACHCMATX
| Q4 25 | $-1.2B | $143.1M | ||
| Q3 25 | $36.2M | $134.7M | ||
| Q2 25 | $30.1M | $94.7M | ||
| Q1 25 | $8.4M | $72.3M | ||
| Q4 24 | $32.6M | $128.0M | ||
| Q3 24 | $68.1M | $199.1M | ||
| Q2 24 | $78.5M | $113.2M | ||
| Q1 24 | $76.4M | $36.1M |
营业利润率ACHCMATX
| Q4 25 | -142.4% | 16.9% | ||
| Q3 25 | 4.7% | 18.3% | ||
| Q2 25 | 5.8% | 13.6% | ||
| Q1 25 | 1.7% | 10.5% | ||
| Q4 24 | 4.9% | 16.6% | ||
| Q3 24 | 12.1% | 25.2% | ||
| Q2 24 | 13.4% | 14.7% | ||
| Q1 24 | 12.9% | 5.1% |
净利率ACHCMATX
| Q4 25 | -143.3% | 16.8% | ||
| Q3 25 | 4.3% | 15.3% | ||
| Q2 25 | 3.5% | 11.4% | ||
| Q1 25 | 1.1% | 9.2% | ||
| Q4 24 | 4.2% | 14.4% | ||
| Q3 24 | 8.4% | 20.7% | ||
| Q2 24 | 9.9% | 13.4% | ||
| Q1 24 | 9.9% | 5.0% |
每股收益（稀释后）ACHCMATX
| Q4 25 | $-12.98 | $4.47 | ||
| Q3 25 | $0.40 | $4.24 | ||
| Q2 25 | $0.33 | $2.92 | ||
| Q1 25 | $0.09 | $2.18 | ||
| Q4 24 | $0.36 | $3.69 | ||
| Q3 24 | $0.74 | $5.89 | ||
| Q2 24 | $0.85 | $3.31 | ||
| Q1 24 | $0.83 | $1.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $141.9M |
| 总债务越低越好 | $2.5B | $361.2M |
| 股东权益账面价值 | $1.9B | $2.8B |
| 总资产 | $5.5B | $4.6B |
| 负债/权益比越低杠杆越低 | 1.28× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ACHCMATX
| Q4 25 | $133.2M | $141.9M | ||
| Q3 25 | $118.7M | $92.7M | ||
| Q2 25 | $131.4M | $59.1M | ||
| Q1 25 | $91.2M | $122.0M | ||
| Q4 24 | $76.3M | $266.8M | ||
| Q3 24 | $82.1M | $270.3M | ||
| Q2 24 | $77.2M | $168.2M | ||
| Q1 24 | $77.3M | $25.9M |
总债务ACHCMATX
| Q4 25 | $2.5B | $361.2M | ||
| Q3 25 | $2.3B | $370.9M | ||
| Q2 25 | $2.3B | $341.3M | ||
| Q1 25 | $2.2B | $351.1M | ||
| Q4 24 | $2.0B | $361.2M | ||
| Q3 24 | $1.9B | $370.9M | ||
| Q2 24 | $1.8B | $381.0M | ||
| Q1 24 | $1.9B | $390.8M |
股东权益ACHCMATX
| Q4 25 | $1.9B | $2.8B | ||
| Q3 25 | $3.1B | $2.7B | ||
| Q2 25 | $3.1B | $2.6B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.1B | $2.7B | ||
| Q3 24 | $3.0B | $2.6B | ||
| Q2 24 | $3.0B | $2.4B | ||
| Q1 24 | $2.9B | $2.4B |
总资产ACHCMATX
| Q4 25 | $5.5B | $4.6B | ||
| Q3 25 | $6.4B | $4.6B | ||
| Q2 25 | $6.3B | $4.5B | ||
| Q1 25 | $6.1B | $4.5B | ||
| Q4 24 | $6.0B | $4.6B | ||
| Q3 24 | $5.9B | $4.4B | ||
| Q2 24 | $5.7B | $4.3B | ||
| Q1 24 | $5.5B | $4.2B |
负债/权益比ACHCMATX
| Q4 25 | 1.28× | 0.13× | ||
| Q3 25 | 0.74× | 0.14× | ||
| Q2 25 | 0.74× | 0.13× | ||
| Q1 25 | 0.72× | 0.13× | ||
| Q4 24 | 0.64× | 0.14× | ||
| Q3 24 | 0.62× | 0.15× | ||
| Q2 24 | 0.62× | 0.16× | ||
| Q1 24 | 0.65× | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $176.9M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $42.2M |
| 自由现金流率自由现金流/营收 | -21.8% | 5.0% |
| 资本支出强度资本支出/营收 | 11.3% | 15.8% |
| 现金转化率经营现金流/净利润 | — | 1.24× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $153.7M |
8季度趋势，按日历期对齐
经营现金流ACHCMATX
| Q4 25 | $-86.3M | $176.9M | ||
| Q3 25 | $73.2M | $175.6M | ||
| Q2 25 | $133.5M | $105.6M | ||
| Q1 25 | $11.5M | $89.0M | ||
| Q4 24 | $116.7M | $174.7M | ||
| Q3 24 | $163.1M | $248.6M | ||
| Q2 24 | $171.1M | $307.9M | ||
| Q1 24 | $-321.3M | $36.6M |
自由现金流ACHCMATX
| Q4 25 | $-179.5M | $42.2M | ||
| Q3 25 | $-63.0M | $92.4M | ||
| Q2 25 | $-34.2M | $19.3M | ||
| Q1 25 | $-163.2M | $-200.0K | ||
| Q4 24 | $-86.8M | $49.3M | ||
| Q3 24 | $-27.1M | $189.0M | ||
| Q2 24 | $16.9M | $238.1M | ||
| Q1 24 | $-463.7M | $-18.7M |
自由现金流率ACHCMATX
| Q4 25 | -21.8% | 5.0% | ||
| Q3 25 | -7.4% | 10.5% | ||
| Q2 25 | -3.9% | 2.3% | ||
| Q1 25 | -21.2% | -0.0% | ||
| Q4 24 | -11.2% | 5.5% | ||
| Q3 24 | -3.3% | 19.6% | ||
| Q2 24 | 2.1% | 28.1% | ||
| Q1 24 | -60.4% | -2.6% |
资本支出强度ACHCMATX
| Q4 25 | 11.3% | 15.8% | ||
| Q3 25 | 16.0% | 9.5% | ||
| Q2 25 | 19.3% | 10.4% | ||
| Q1 25 | 22.7% | 11.4% | ||
| Q4 24 | 26.3% | 14.1% | ||
| Q3 24 | 23.3% | 6.2% | ||
| Q2 24 | 19.4% | 8.2% | ||
| Q1 24 | 18.5% | 7.7% |
现金转化率ACHCMATX
| Q4 25 | — | 1.24× | ||
| Q3 25 | 2.02× | 1.30× | ||
| Q2 25 | 4.43× | 1.12× | ||
| Q1 25 | 1.37× | 1.23× | ||
| Q4 24 | 3.58× | 1.36× | ||
| Q3 24 | 2.39× | 1.25× | ||
| Q2 24 | 2.18× | 2.72× | ||
| Q1 24 | -4.21× | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
MATX
| Ocean Transportation Segment | $704.2M | 83% |
| Logistics Services Segment | $147.7M | 17% |
